Connor, Clark & Lunn Investment Management (CC&L)’s Agilon Health AGL Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$160K	Sell	20,283 -1,323	-6%	-$21.4K	﹤0.01%	1491
2025 Q4	$372K	Sell	21,606 -276	-1%	-$5.35K	﹤0.01%	1358
2025 Q3	$563K	Sell	21,882 -9,706	-31%	-$367K	﹤0.01%	1225
2025 Q2	$1.82M	Buy	31,588 +28,790	+1,029%	+$2.31M	0.01%	886
2025 Q1	$303K	Buy	+2,798	New	+$244K	﹤0.01%	1247

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s AGL Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Agilon Health (AGL) stake by 6.1% in Q1 2026, selling an estimated $21.4K and leaving 20,283 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #1491.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in AGL in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.82M in Q2 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

Connor, Clark & Lunn Investment Management (CC&L) held 20,283 shares of Agilon Health worth $160K as of Q1 2026.
Connor, Clark & Lunn Investment Management (CC&L) sold 1,323 Agilon Health shares in Q1 2026, an estimated $21.4K.
Agilon Health made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #1491 holding.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Agilon Health in Q1 2025 and has held it in 5 quarters since.
Connor, Clark & Lunn Investment Management (CC&L)'s Agilon Health position peaked at $1.82M in Q2 2025.
97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.